Immix Biopharma's total assets for Q3 2025 were $20.08M, an increase of 28.43% from the previous quarter. IMMX total liabilities were $11.82M for the fiscal quarter, a 7.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.